• Self-reported irregular menstrual cycles defined by one or more of the following: cycle length usually over 35 days or under 21 days; fewer than 9 menstrual periods in the past year; unpredictable cycle timing varying by more than 7 days month-to-month; irregular cycles present for at least 6 months
• One or more hormonal balance concerns such as skin issues, unwanted hair growth, hair thinning, or weight concerns
• Self-reported emotional symptoms that fluctuate with the menstrual cycle including mood swings, irritability, stress, low mood, or difficulty regulating emotions
• Not currently using hormonal therapies, metformin, GLP-1 receptor agonists, or anti-androgens
• Willing to stop supplements for menstrual or hormonal support for a 2-week washout before baseline if currently taking any
• Weight stable within plus or minus 5 pounds for the past 2 months and not planning to start a new diet, exercise program, or medications during the study
• Able to provide electronic informed consent
• Willing to complete online surveys and at-home dried blood spot sample collection
• Negative home pregnancy test at baseline
• Access to a computer or smartphone and reliable internet connection

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety